Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Tiziana Claudia Aranzulla Added: 9 months ago
ESC Congress 2025 - Evolocumab on top of lipid lowering therapy(LLT) reduced adverse vascular events at 12 months.Dr Tiziana Claudia Aranzulla (Mauriziano Umberto Hospital, Turin, IT) joins us to discuss findings from CARUSO (NCT04730973). The trial aimed to assess the efficacy of evolocumab with traditional LLT compared to traditional LTT alone in the stabilisation and regression of carotid… View more
Added: 4 months ago Source:  Radcliffe Vascular
The optimal management for asymptomatic carotid stenosis has been a subject of debate, particularly with advancements in medical therapy. New findings from the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) provide clarity, suggesting a benefit for carotid-artery stenting when added to intensive medical management.¹MethodologyCREST-2 involved… View more
Added: 4 months ago Source:  Radcliffe Vascular
The optimal management for patients with high-grade asymptomatic carotid stenosis remains a key clinical question, particularly with advancements in medical therapy and revascularisation techniques. The CREST-2 trials were designed to assess whether adding revascularisation to intensive medical management provides a greater benefit than intensive medical management alone in this patient… View more
Author(s): Andrea M Steely Added: 7 months ago
Navigate the evolving landscape of surgical coronary revascularization with Dr Andrea SteelyThis presentation, part of the Complex Cases track in Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of traditional and contemporary approaches to treating coronary artery disease.Dr Steely examines traditional coronary artery bypass grafting (CABG) alongside… View more
Author(s): Andrew Holden Added: 1 year ago
What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II… View more
Author(s): Hossameldin Hussein Added: 1 year ago
CCTA, axial section, showing the main pulmonary artery anteriorly related to ascending aorta, the LM trunk bifurcating into LAD and Ramus, and the LCX originating from the posterior right sinus with abnormal course. View more